SCHEMBL847892

SCHEMBL847892

COCCOC(=O)C1(C)COC(=O)OC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 3/20 0.33
ATM Q13315 1/20 0.33
KDM4E B2RXH2 3/20 0.32
HSD17B10 Q99714 2/20 0.32
ALOX15 P16050 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
POLB P06746 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HSP90AB1 P08238 1/20 0.32
CASP3 P42574 1/20 0.32
CDC37 Q16543 1/20 0.32
LIPE Q05469 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL846905 0.95 SMN1; SMN2 (0.34) SMN1; SMN2TSHRMEN1KMT2AALDH1A1
SCHEMBL17589272 0.95 SMN1; SMN2 (0.34) SMN1; SMN2TSHRMEN1KMT2AALDH1A1
SCHEMBL18415749 0.87 ATM (0.32) ATM
SCHEMBL10260787 0.85 ATM (0.37) TSHRALDH1A1ATMKDM4ETDP1
SCHEMBL2053633 0.84 ALDH1A1 (0.42) TSHRMEN1KMT2AALDH1A1ATM
SCHEMBL18256737 0.83 ATM (0.33) ATM
SCHEMBL14771785 0.83 ATM (0.33) SMN1; SMN2ATM
SCHEMBL847155 0.83 ATM (0.33) ATM
SCHEMBL15692235 0.83 ATM (0.33) ATM
SCHEMBL28839191 0.83 ALDH1A1 (0.41) TSHRMEN1KMT2AALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114051530-A Cell scaffold material, cell culture support, and method for culturing cells 昭和电工材料株式会社 2022-02-15 CN disclosed
US-20180134845-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2018-05-17 US disclosed
US-9868821-B2 Polymeric nanogels with degradable backbones and from gras components, and compositions and methods thereof UNIVERSITY OF MASSACHUSETTS (US) 2018-01-16 US disclosed
US-20170202217-A1 ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (JP) 2017-07-20 US disclosed
US-20170202217-A1 ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (JP) 2017-07-20 US disclosed
US-20160075829-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2016-03-17 US disclosed
US-8940855-B2 Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2015-01-27 US disclosed
US-8846851-B2 Methods of ring opening polymerization and catalysts therefor INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-09-30 US disclosed
WO-2014133102-A1 BIOCOMPATIBLE POLYMER AS ANTITHROMBOGENIC MATERIAL, CYCLIC CARBONATE USEFUL AS PRECURSOR THEREOF, AND METHOD FOR PRODUCING SAME 国立大学法人山形大学 (JP) 2014-09-04 WO disclosed
US-8779166-B2 Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-07-15 US disclosed
US-20120178891-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF CENTRAL GLASS CO., LTD. (JP) 2012-07-12 US disclosed
US-20120172559-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-07-05 US disclosed
US-20120172602-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-07-05 US disclosed
US-20120172603-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-07-05 US disclosed
US-8207351-B2 Cyclic carbonyl compounds with pendant carbonate groups, preparations thereof, and polymers therefrom INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-06-26 US disclosed
US-8143369-B2 Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-03-27 US disclosed
US-20120046437-A1 METHODS OF RING OPENING POLYMERIZATION AND CATALYSTS THEREFOR INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-02-23 US disclosed
US-20110269917-A1 CYCLIC CARBONYL COMPOUNDS WITH PENDANT CARBONATE GROUPS, PREPARATIONS THEREOF, AND POLYMERS THEREFROM CENTRAL GLASS CO., LTD. (JP) 2011-11-03 US disclosed
US-20110054064-A1 Hydrogel Compositions and Methods of Preparation Thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-03-03 US disclosed
US-20100305281-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172603-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF PFAS, PAM, PCNA SMN1; SMN2 770/4885TSHR 1728/4885MEN1 2426/4885
US-20170202217-A1 ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF WASF2, HASPIN, MRPL21 SMN1; SMN2 3373/4885TSHR 3953/4885MEN1 2667/4885
US-20160075829-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF CD44, PGLS, HPSE SMN1; SMN2 2957/4885TSHR 3710/4885MEN1 4029/4885
US-20180134845-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF CD44, PGLS, HPSE SMN1; SMN2 2957/4885TSHR 3710/4885MEN1 4029/4885
US-20100305281-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF PFAS, PAM, PCNA SMN1; SMN2 770/4885TSHR 1728/4885MEN1 2426/4885
US-20110269917-A1 CYCLIC CARBONYL COMPOUNDS WITH PENDANT CARBONATE GROUPS, PREPARATIONS THEREOF, AND POLYMERS THEREFROM NOTUM, PFAS, PCNA SMN1; SMN2 1100/4885TSHR 3395/4885MEN1 3439/4885
US-20120046437-A1 METHODS OF RING OPENING POLYMERIZATION AND CATALYSTS THEREFOR OGFOD1, PCNA, ODC1 SMN1; SMN2 3036/4885TSHR 4297/4885MEN1 1598/4885
US-20120172602-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF PFAS, PAM, PCNA SMN1; SMN2 770/4885TSHR 1728/4885MEN1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.